NCT03901014

Brief Summary

The purpose of this study is to understand how the reduction in dietary carbohydrates in a very-low carbohydrate ketogenic diet impacts the synthesis of cholesterol, fatty acid, and ketones, and the turnover rate of VLDL and chylomicron particles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

March 31, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 3, 2019

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2019

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

18 days

First QC Date

March 29, 2019

Last Update Submit

November 7, 2022

Conditions

Keywords

ketogenic dietLDL cholesterolcarbohydrate

Outcome Measures

Primary Outcomes (4)

  • Change in total cholesterol

    Change in serum total cholesterol between Day 3-7 (average value) to Day 17-21 (average value)

    Day 3-7 to Day 17-21

  • Change in low density lipoprotein (LDL) cholesterol

    Change in serum LDL cholesterol between Day 3-7 (average value) to Day 17-21 (average value)

    Day 3-7 to Day 17-21

  • Change in high density lipoprotein (HDL) cholesterol

    Change in serum HDL cholesterol between Day 3-7 (average value) to Day 17-21 (average value)

    Day 3-7 to Day 17-21

  • Change in apolipoprotein B (apoB) kinetics

    Change in apoB turnover rates in LDL and very low density lipoprotein plasma fractions as measured using 2H2 leucine incorporation into apoB and mathematical modeling

    Day 3-7 to Day 17-21

Secondary Outcomes (9)

  • Change in fractional hepatic de novo lipogenesis

    Day 3 to Day 17

  • Change in fractional cholesterol synthesis

    Day 3 to Day 17

  • Change in ketone body synthesis

    Day 3 to Day 17

  • Change in TRL-triglyceride kinetics

    Day 3 to Day 17

  • Change in triglyceride lipolysis

    Day 3 to Day 17

  • +4 more secondary outcomes

Study Arms (2)

Baseline diet

ACTIVE COMPARATOR

1 week baseline diet

Other: Standard American diet

Very low carbohydrate diet

EXPERIMENTAL

2 week very low carbohydrate ketogenic diet

Other: Very low carbohydrate diet

Interventions

Standard American diet with 50% energy from carbohydrate, 30% from fat, and 20% from protein.

Baseline diet

Ketogenic diet with \<50g carbohydrate, 60-75% energy from fat, and 20% from protein

Very low carbohydrate diet

Eligibility Criteria

Age18 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • years old

You may not qualify if:

  • Use of nicotine products
  • Has dietary restrictions
  • Lactose intolerance
  • History of GI disorders, diabetes, liver, kidney, or thyroid disorders
  • Taking hypolipidemic, anti-diabetic, anti-hypertensive, or anti-depression medication
  • Screening plasma triglyceride \< 50mg/dl or \>500mg/dl
  • Screening glucose \> 125mg/dl
  • Screening total and LDL-Cholesterol over 95th %tile for age and sex
  • BP \> 160/95 mmHg
  • Weight loss/gain \> 5% in the previous 3 months (self-reported)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Touro University California

Vallejo, California, 94592, United States

Location

Study Officials

  • Grace M Jones, PhD

    Touro University, California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
The nature of the diet does not allow for masking
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2019

First Posted

April 3, 2019

Study Start

March 31, 2019

Primary Completion

April 18, 2019

Study Completion

April 18, 2019

Last Updated

November 9, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations